Topiramate Capsule, Coated Pellets
Product Images NDC 70518-4247

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-4247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 01)

FDA Label Image

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 02)

Structured Product Formula For Topiramate (61ea1fc2 B691 4c09 Ac57 B37347dba975 02)
This excerpt provides information on cumulative rates for time to the first seizure for two different doses of topiramate - 50 mg/day and 400 mg/day. The data includes the number of participants (N) for each dose group and a p-value indicating a statistically significant difference between the two groups. The graph also shows time in days on the x-axis and cumulative rates on the y-axis.*
FDA Label Image

Topiramate Tablets Usp (61ea1fc2 B691 4c09 Ac57 B37347dba975 03)

Topiramate Tablets Usp (61ea1fc2 B691 4c09 Ac57 B37347dba975 03)
This text appears to show data related to the change in average monthly migraine period rate from baseline to the double-blind phase for different dosages of topiramate and a placebo. The different treatment groups mentioned include placebo, topiramate at 50mg/day, 100mg/day, and 200mg/day. The text indicates statistical significance with different levels of p-values.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This information provides details about a medication called Topiramate in 25 mg capsules packed in a quantity of 30 per box. The prescription is only for use as indicated by a healthcare professional. The manufacturer is Zydus Pharmaceuticals located in Pennington, NJ, and the medication should be stored at temperatures between 20-25°C (58-77°F). The text also includes information about the repackaging of the medication by Remedy Repack Inc. in Indiana, PA. Please refer to the package insert for directions for use.*
FDA Label Image

Mm2 (Topiramate 25mg 70518 4247 01)

Mm2 (Topiramate 25mg 70518 4247 01)
This is a description of Topiramate, a medication available in a 25 mg capsule. The medication is packaged by Orepac HD2 and is for prescription use only. It includes the NDC number, expiration date, manufacturing details by Zydus Pharm located in Pennington, NJ, and instructions to keep it out of reach of children. It is repackaged by Remedy Repack Inc. in Indiana, PA. Storage instructions and contact information for Remedy Repack Inc. are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.